Schizophrenia News and Research

Latest Schizophrenia News and Research

Mouse study uncovers how marijuana may damage some adolescent brains

In a study of adolescent mice with a version of a gene linked to serious human mental illnesses, Johns Hopkins Medicine researchers say they have uncovered a possible explanation for how marijuana may damage the brains of some human teens.

18 Dec 2018

Study finds epigenetic differences in the brains of individuals with schizophrenia

A study using a PET scan tracer developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital has identified, for the first time, epigenetic differences between the brains of individuals with schizophrenia and those of unaffected study participants.

17 Dec 2018

Researchers uncover microRNAs involved in the control of social behavior

The recent discovery of microRNAs as key regulators of biological processes has fueled an explosion of research activity into their function in health and disease.

14 Dec 2018

New research lays out potential path for treatment of Huntington’s disease

New research gives scientists a clearer picture of what is happening in the brains of people with Huntington's disease and lays out a potential path for treatment.

14 Dec 2018

Findings reinforce guidelines for cautious use of antipsychotics in younger populations

Children and young adults without psychosis who are prescribed high-dose antipsychotic medications are at increased risk of unexpected death, despite the availability of other medications to treat their conditions, according to a Vanderbilt University Medical Center study published today in JAMA Psychiatry.

13 Dec 2018

New study reveals yin-yang personality of dopamine

For decades, psychologists have viewed the neurotransmitter dopamine as a double-edged sword: released in the brain as a reward to train us to seek out pleasurable experiences, but also a "drug" the constant pursuit of which leads to addiction.

11 Dec 2018

Researchers confirm link between neonatal vitamin D deficiency and schizophrenia

Newborns with vitamin D deficiency have an increased risk of schizophrenia later in life, a team of Australian and Danish researchers has reported.

7 Dec 2018

$Chronic, refractory schizophrenia patients benefit from targeted cognitive training$

Chronic, refractory schizophrenia patients benefit from targeted cognitive training

Schizophrenia is among the most difficult mental illnesses to treat, in part because it is characterized by a wide range of dysfunction, from hallucinations and mood disorders to cognitive impairment, especially verbal and working memory, which can be explained in part by abnormalities in early auditory information processing.

6 Dec 2018

Newborns with vitamin D deficiency have increased risk of schizophrenia later in life

Newborns with Vitamin D deficiency have an increased risk of schizophrenia later in life, researchers from Aarhus University and the University of Queensland report.

6 Dec 2018

Study shows correlation between childhood infections and increased risk of mental disorders

A new study from iPSYCH shows that the infections children contract during their childhood increase the risk of mental disorders during childhood and adolescence. This knowledge expands our understanding of the role of the immune system in the development of mental disorders.

6 Dec 2018

Cedars-Sinai research identifies neurons that play role in how people recognize errors

New research from Cedars-Sinai has identified neurons that play a role in how people recognize errors they make, a discovery that may have implications for the treatment of conditions including obsessive-compulsive disorder and schizophrenia.

5 Dec 2018

Maryland researchers receive grant to study the brain-to-gut connection in schizophrenia

Researchers at the University of Maryland School of Medicine's Maryland Psychiatric Center and Institute for Genome Sciences, along with researchers at the University of Maryland School of Pharmacy, have been awarded a collaborative five-year $1.78 million grant to study the brain-to-gut connection in schizophrenia.

5 Dec 2018

Study identifies new potential target for treating major common diseases

There is a large, untapped potential for developing drugs against cancer, fibrosis and cardiovascular diseases by targeting a family of receptors known as Frizzleds, researchers at Karolinska Institutet in Sweden believe. In a new study published in Science Signaling, they identify how these receptors are activated in the cell membrane and the processes that are then triggered within the cell.

4 Dec 2018

Scientists alleviate schizophrenic symptoms in mice

Despite extensive research efforts, schizophrenia remains one of the least understood brain disorders. One promising area of research is in receptors on the surfaces of brain cells that help sense growth factors.

30 Nov 2018

UNLV researchers suggest new way to classify negative symptoms of schizophrenia

The onset of schizophrenia in young adults can put an immediate halt to life goals, with one set of symptoms being particularly debilitating.

28 Nov 2018

Researchers discover first common genetic risk factors associated with ADHD

A global team of researchers has found the first common genetic risk factors associated with attention deficit hyperactivity disorder, a complex condition affecting around 1 in 20 children.

27 Nov 2018

BIO issues statement on proposed changes to Medicare Part D and Medicare Advantage plans

BIO President and CEO Jim Greenwood issued the following statement regarding today's proposed changes to Medicare Part D and Medicare Advantage plans.

26 Nov 2018

Study finds genetic links between alcohol dependence and psychiatric disorders

In the largest study of genetic factors linked to alcohol dependence, an international team of researchers identified a gene known to affect risk, and they determined that many other genes also contribute to risk for alcohol dependence to a lesser degree.

26 Nov 2018

Research team urges shake-up in mental health provision to enhance patient care

A new study published in the journal Social Theory & Health has called into question how patients interact and respond to psychiatry when they present to mental health services.

22 Nov 2018

Smokers at greater risk of schizophrenia and psychotic disorders

A team of researchers from University of Queensland have found that tobacco use is associated with an increased risk of psychotic disorders including schizophrenia.

21 Nov 2018

Schizophrenia News and Research

Latest Schizophrenia News and Research

Mouse study uncovers how marijuana may damage some adolescent brains

Study finds epigenetic differences in the brains of individuals with schizophrenia

Researchers uncover microRNAs involved in the control of social behavior

New research lays out potential path for treatment of Huntington’s disease

Findings reinforce guidelines for cautious use of antipsychotics in younger populations

New study reveals yin-yang personality of dopamine

Researchers confirm link between neonatal vitamin D deficiency and schizophrenia

Chronic, refractory schizophrenia patients benefit from targeted cognitive training

Newborns with vitamin D deficiency have increased risk of schizophrenia later in life

Study shows correlation between childhood infections and increased risk of mental disorders

Cedars-Sinai research identifies neurons that play role in how people recognize errors

Maryland researchers receive grant to study the brain-to-gut connection in schizophrenia

Study identifies new potential target for treating major common diseases

Scientists alleviate schizophrenic symptoms in mice

UNLV researchers suggest new way to classify negative symptoms of schizophrenia

Researchers discover first common genetic risk factors associated with ADHD

BIO issues statement on proposed changes to Medicare Part D and Medicare Advantage plans

Study finds genetic links between alcohol dependence and psychiatric disorders

Research team urges shake-up in mental health provision to enhance patient care

Smokers at greater risk of schizophrenia and psychotic disorders

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Schizophrenia News and Research

Latest Schizophrenia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in